-
NPPA is readying mechanism to ease COVID-19 vaccine supply, prevent unethical practices
expresspharma
September 17, 2020
The government is in talks with experts and stakeholders to increase access to COVID-19 vaccines, bring down their costs and smoothen supply chain, reveal sources.
-
Valneva inks €1.37bn Covid-19 vaccine supply deal with UK
pharmaceutical-technology
September 16, 2020
Speciality vaccines developer Valneva has announced a partnership worth €1.37bn with the UK Government to supply its inactivated Covid-19 vaccine candidate, VLA2001.
-
Pfizer, Biontech Propose Expansion of Pivotal COVID-19 Vaccine Trial
americanpharmaceuticalreview
September 16, 2020
Pfizer and BioNTech have submitted an amended protocol to the U.S. Food and Drug Administration (FDA) to expand the enrollment of their Phase 3 pivotal COVID-19 vaccine trial to up to approximately 44,000 participants which also allows for the ...
-
UK researchers to test inhaled versions of Oxford and Imperial COVID-19 vaccine candidates
expresspharma
September 16, 2020
Delivering the vaccine to the respiratory tract may be a good approach to inducing immune responses in the best place to enable a rapid response after exposure to airborne virus, say researchers.
-
Novavax expands deal with Serum Institute, aims for two billion COVID-19 vaccine doses
expresspharma
September 16, 2020
Serum Institute will also manufacture the antigen component of the vaccine, dubbed NVX‑CoV2373.
-
CSIR and Aurobindo Pharma to collaborate for COVID-19 vaccine development
expresspharma
September 16, 2020
DBT is also supporting Aurobindo Pharma’s COVID-19 vaccine development through its wholly-owned US subsidiary Auro Vaccines, under the National Biopharma Mission.
-
Clinical trial for AstraZeneca Oxford COVID-19 vaccine candidate to resume
europeanpharmaceuticalreview
September 15, 2020
After the clinical trial for AZD1222 was halted last week, the studies for AstraZeneca’s COVID-19 vaccine candidate will now resume.
-
NII’s COVID-19 vaccine candidate exhibits positive results in immunogenicity study on mice
expresspharma
September 14, 2020
The Director of the Institute said that more tests need to be done on mice on a larger scale now and it is expected to start next week.
-
COVAXIN demonstrates protective efficacy in animal studies: Bharat Biotech
expresspharma
September 14, 2020
A two-dose vaccination regimen, administered in 20 rhesus macques, showed increasing SARS-CoV-2 specific IgG and neutralizing antibodies, reducing replication of the virus in the nasal cavity, throat, and lung tissues.
-
Clinical Trial of AstraZeneca COVID-19 Vaccine Paused After Illness
drugs.com
September 10, 2020
A "potentially unexplained" illness in a participant has led AstraZeneca to halt a late-stage clinical trial of its COVID-19 vaccine.